Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

Ratios

vs
industry
vs
history
P/E(ttm) 15.54
PID's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 15.54 )
Ranked among companies with meaningful P/E(ttm) only.
PID' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 15.59
Current: 15.54
0
15.59
PE(NRI) 15.54
PID's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 15.54 )
Ranked among companies with meaningful PE(NRI) only.
PID' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 15.59
Current: 15.54
0
15.59
P/B 1.47
PID's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 1.47 )
Ranked among companies with meaningful P/B only.
PID' s P/B Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 1.47
Current: 1.47
0
1.47

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 3.90
PID's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 3.90 )
Ranked among companies with meaningful Dividend Yield only.
PID' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 3.92
Current: 3.9
0
3.92
Yield on cost (5-Year) 3.90
PID's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 3.90 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
PID' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 3.92
Current: 3.9
0
3.92

More Statistics

Short Percentage of Float0.00%
52-Week Range $11.44 - 16.19
Shares Outstanding (Mil)46,550,000.00
» More Articles for PID

Headlines

Articles On GuruFocus.com
Dodge & Cox Stock Fund 2nd Quarter Commentary Jul 29 2016 
Barrick Releases Second Quarter Report Jul 29 2016 
Ariel Investments' Charlie Bobrinskoy Discusses European Stress Test Results Jul 29 2016 
Sometimes It Is Good to Buy the Biggest. But Should You Buy the Biggest Health Care Distribution Bus Jul 29 2016 
How Are We Doing?: A Second Look at Conn's Jul 29 2016 
Matthews China Fund Made 6 New Buys in 2nd Quarter Jul 29 2016 
The Carlyle Group Is a Screaming Buy Jul 29 2016 
What UPS Earnings Tell Us About This Logistics Behemoth Jul 29 2016 
Linear Technology: We Hardly Knew 'Ya - Part Two Jul 29 2016 
Twitter's Not Getting My Money...Yet Jul 29 2016 

More From Other Websites
What to Expect from Shire’s Genetic Disease Franchise Jul 28 2016
What Role Did Innovative Medicines Play in Novartis’s 2Q16 Earnings? Jul 22 2016
How Did Novartis’s 2Q16 Earnings Stand up to Analyst Estimates? Jul 21 2016
Novartis’s 2Q16 Earnings: What’s Expected? Jul 18 2016
How Could the Novartis-Xencor Alliance Benefit Novartis? Jul 01 2016
What Is Xencor’s XmAb Technology? Jun 30 2016
A New Idea Among International Dividend ETFs Jun 30 2016
Could Novo Nordisk’s 2016 Earnings Impress Wall Street? Jun 28 2016
Evaluating Novo Nordisk’s Efficiency Based on EV-to-EBITDA Jun 27 2016
Revisiting An International Dividend ETF Jun 24 2016
International ETFs For Investors Looking To Balance Income, Growth Jun 17 2016
5 Best Smart Beta ETFs That Pay Dividends (PID, ICF) Jun 15 2016
6 Best ETF Picks: Investing Nimbly With Some Excitement Thrown In Jun 10 2016
Major Developments for Sanofi in 1Q16 May 25 2016
Sanofi’s Diabetes and Cardiovascular Franchise Performance May 24 2016
New International Dividend Growth ETF by iShares in Focus May 24 2016
Why PotashCorp’s Gross Margins Fell in 1Q16 May 20 2016
A Peek at Sanofi’s Valuation Cheat Sheet May 19 2016
Novo’s Geographical Sales Split in 1Q16 May 06 2016
Why Did Agrium Perform Better Than Expected in 1Q16? May 06 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK